Conclusions
Rapid advances in technology provide a good platform for the systemic cataloging and characterization of the normal and cancerous phenotype and underlying genotype of PCA. This should set the stage for the development of new prognostic and therapeutic strategies. The understanding of genetic events which occur during the progression of PIN and other preneoplastic lesions to PCA would be useful for prevention, early detection, and treatment of this common disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sakr WA, Grignon DJ, Crissman JD, et al (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 8:439–443.
Hsing AW, Deng J, Sesterhenn IA, et al (2000) Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 9:1335–1341.
Gann PH, Ma J, Giovannucci E, et al (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59:1225–1230.
Giovannucci E, Rimm EB, Colditz GA, et al (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571–1579.
De Marzo AM, Putzi MJ, Nelson WG (2001) New concepts in the pathology of prostatic epithelial carcinogenesis. Urology 57:103–114.
Bostwick DG (1989) Prostatic intraepithelial neoplasia (PIN). Urology 34:16–22.
Bostwick DG (2000) Prostatic intraepithelial neoplasia. Curr Urol Rep 1:65–70.
McNeal JE, Villers A, Redwine EA, et al (1991) Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol 22:644–652.
Weinberg DS, Weidner N (1993) Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Arch Pathol Lab Med 117:1132–1137.
Colombel M, Symmans F, Gil S, et al (1993) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390–400.
Helpap B, Riede C (1995) Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma. Pathol Res Pract 191:381–390.
Magi-Galluzzi C, Murphy M, Cangi MG, et al (1998) Proliferation, apoptosis and cell cycle regulation in prostatic carcinogenesis. Anal Quant Cytol Histol 20:343–350.
Magi-Galluzzi C, Montironi R, Prete E, et al (1996) Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma. Anticancer Res 16:2931–2936.
Magi-Galluzzi C, Xu X, Hlatky L, et al (1997) Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pathol 10:839–845.
Luo J, Zha S, Gage W, et al (2002) Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 62:2220–2226.
Magi-Galluzzi C, Luo J, Isaacs WB, et al (2003) Alpha-methylacyl-coA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 27:1128–1133.
Rubin MA, Zhou M, Dhanasekaran SM, et al (2002) Alpha-methyl-acyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287:1662–1670.
Brooks JD, Weinstein M, Lin X, et al (1998) CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7:531–536.
Lee WH, Isaacs WB, Bova GS, et al (1997) CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 6:443–450.
Lee WH, Morton RA, Epstein JI, et al (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91:11733–11737.
Nakayama M (2003) Hypermethylation of the human GSTP1 CpG island is present in a subset of proliferative inflammatory atrophy lesions but not normal or hyperplastic epithelium of the prostate: a detailed study using laser capture microdissection. Am J Pathol 163:923–933.
Qian J, Jenkins RB, Bostwick DG (1999) Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol 35:479–483.
McClintock B (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 26:234–282.
Meeker AK, Garcia-Moreno B, Shortle D (1996) Contributions of the ionizable amino acids to the stability of staphylococcal nuclease. Biochemistry 35:6443–6449.
Meeker AK, Sommerfeld HJ, Coffey DS (1996) Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology 137:5743–5746.
Sommerfeld HJ, Meeker AK, Piatyszek MA, et al (1996) Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56:218–222.
Meeker AK, Hicks JL, Platz EA, et al (2002) Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 62:6405–6409.
Vukovic B, Park PC, Al-Maghrabi J, et al (2003) Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene 22:1978–1987.
Bartsch H, Frank N (1996) Blocking the endogenous formation of N-nitroso compounds and related carcinogens. IARC Sci Publ, 189–201.
Weitzman SA, Gordon LI (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655–663.
Nelson WG, DeMarzo AM, DeWeese TL (2001) The molecular pathogenesis of prostate cancer: focus on the earliest steps. Eur Urol 39Suppl 4:8–11.
McNeal JE (1968) Regional morphology and pathology of the prostate. Am J Clin Pathol 49:347–357.
Franks LM (1954) Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 68:617–621.
McNeal JE, Redwine EA, Freiha FS, et al (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897–906.
Billis A. 1998. Prostatic atrophy: An autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 11:47–54.
Gardner WA, Jr., Culberson DE (1987) Atrophy and proliferation in the young adult prostate. J Urol 137:53–56.
Liavag I (1968) Atrophy and regeneration in the pathogenesis of prostate carcinoma. Acta Pathol Microbiol Scan 73:338–350.
McNeal JE (1997) Prostate cancer volume. Am J Surg Pathol 21:1392–1393.
Anton RC, Kattan MW, Chakraborty S, et al (1999) Post atrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 23:932–936.
Billis A, Luis AM (2003) Inflammatory Atrophy of the prostate. Arch Pathol Lab Med 127:840–844.
Feneley MR, Young MP, Chinyama C, et al (1996) Ki-67 expression in early prostate cancer and associated pathological lesions. J Clin Pathol 49:741–748.
Ruska KM, Sauvageot J, Epstein JI (1998) Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 22:1073–1077.
De Marzo AM, Marchi VL, Epstein JI, et al (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155:1985–1992.
Putzi MJ, De Marzo A (2000) Morphological transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 56:828–832.
Bonkhoff H, Stein U, Remberger K (1994) The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 22:114–118.
Giannulis I, Montironi R, Magi-Galluzzi C, et al (1993) Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN). Anticancer Res 13:2447–2452.
McNeal JE, Haillot O, Yemoto C (1995) Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 27:258–268.
van Leenders GJ, Gage WR, Hicks JL et al (2003) Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 162:1529–1537.
Verhagen AP, Ramaekers FC, Aalders TW, et al (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52:6182–6187.
Cordon-Cardo C, Koff A, Drobnjak M, et al (1998) Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90:1284–1291.
De Marzo AM, Meeker AK, Epstein JI, et al (1998) Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 153:911–919.
Lloyd RV, Erickson LA, Jin L, et al (1999) p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154:313–323.
Brawn PN (1982) Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 49:826–833.
McNeal JE (1978) Origin and evolution of benign prostatic enlargement. Invest Urol 15:340–345.
Bostwick DG, Qian J (1995) Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 19:506–518.
Gaudin PB, Epstein JI (1994) Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 18:863–870.
Gaudin PB, Epstein JI (1995) Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 19:737–747.
Pinto JT, Qiao C, Xing J, et al (2000) Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine. Prostate 45:304–314.
Yang XJ, Wu CL, Woda BA, et al (2002) Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26:921–925.
Cheng L, Shan A, Cheville JC, et al (1998) Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 58:389–391.
Doll JA, Zhu X, Furman J, et al (1999) Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 155:967–971.
McNeal JE (1965) Morphogenesis of prostatic carcinoma. Cancer 18:1659–1666.
Erbersdobler A (2002) Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 41:40–46.
Armenian HK, Lilienfeld AM, Diamond EL, et al (1974) Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study. Lancet 2:115–117.
Greenwald P, Kirmss V, Polan AK, et al (1974) Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53:335–340.
Guess HA (2001) Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev 23:152–158.
Leav I, McNeal JE, Ho SM, et al (2003) Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Hum Pathol 34:228–233.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Magi-Galluzzi, C., De Marzo, A.M. (2005). Prostate Epithelial Carcinogenesis: Putative and Controversial Precursor Lesions. In: Li, J.J., Li, S.A., Llombart-Bosch, A. (eds) Hormonal Carcinogenesis IV. Springer, Boston, MA. https://doi.org/10.1007/0-387-23761-5_12
Download citation
DOI: https://doi.org/10.1007/0-387-23761-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23783-1
Online ISBN: 978-0-387-23761-9
eBook Packages: MedicineMedicine (R0)